This thesis aims to provide a framework for analyzing the moral responsibilities of the global players in what I call the Global Health Crisis (henceforth GHC), with special attention devoted to the moral responsibilities of pharmaceutical companies. I defend the following claim: while all global players share certain responsibilities in remediating the negative effects of the GHC, different degrees of responsibility apply to different players...